AAC Generative Language Intervention
BehavioralParent/Caregiver AAC App Operational Training + Direct AAC Input-Output Language Intervention
NCT Number: NCT03538925
The focus of this investigation is to compare the effectiveness of the AAC Generative Language Intervention approach to an AAC Standard of Care condition on preschool sentence productions. All children will use existing AAC iPad applications.
Looking for future studies?
Notify Me3 year–4 year
All sexes
Interventional
Phase 2
FAAST Center at the University of Central Florida, Orlando, Florida, United States
The central hypothesis is that preschoolers receiving AAC Generative Language Intervention will create longer, more grammatically complete sentences compared with the Standard of Care condition. Specific Aim 1 compares these interventions for preschoolers with severe speech impairments and typical receptive language, and Specific Aim 2 does the same for children with Down syndrome. Specific Aim 3 tests for possible moderation of the intervention effect by age, dynamic assessment scores, sentence type, receptive language abilities, prior AAC use, sex, mental age, and disability. Aims 1 and 2 will be accomplished using randomized controlled trials.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Parent/Caregiver AAC App Operational Training + Direct AAC Input-Output Language Intervention
Parent/Caregiver AAC App Operational Training
Time frame: 6 Months
Aided AAC sentence length measured in morphemes
University of Central Florida
Other
Word by Word: Building Sentences With Preschoolers Who Use AAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06512168
Abnormalities, Multiple, Apraxia of Speech
Orlando, Florida, United States
View Trial DetailsNCT03698539
Abnormalities, Multiple, Behavior
Leuven, Belgium
View Trial DetailsNCT02158390
Abnormalities, Multiple, Chromosome Disorders
Los Angeles, California, United States
View Trial DetailsNCT07044804
Abnormalities, Multiple, Behavior
Rome, Italy
View Trial Details